全文获取类型
收费全文 | 9804篇 |
免费 | 918篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 378篇 |
妇产科学 | 335篇 |
基础医学 | 1398篇 |
口腔科学 | 160篇 |
临床医学 | 1279篇 |
内科学 | 1816篇 |
皮肤病学 | 172篇 |
神经病学 | 985篇 |
特种医学 | 235篇 |
外科学 | 945篇 |
综合类 | 203篇 |
一般理论 | 24篇 |
预防医学 | 1146篇 |
眼科学 | 285篇 |
药学 | 648篇 |
中国医学 | 10篇 |
肿瘤学 | 655篇 |
出版年
2023年 | 88篇 |
2022年 | 126篇 |
2021年 | 207篇 |
2020年 | 197篇 |
2019年 | 233篇 |
2018年 | 235篇 |
2017年 | 213篇 |
2016年 | 200篇 |
2015年 | 230篇 |
2014年 | 359篇 |
2013年 | 481篇 |
2012年 | 682篇 |
2011年 | 614篇 |
2010年 | 369篇 |
2009年 | 325篇 |
2008年 | 603篇 |
2007年 | 593篇 |
2006年 | 569篇 |
2005年 | 586篇 |
2004年 | 536篇 |
2003年 | 441篇 |
2002年 | 429篇 |
2001年 | 148篇 |
2000年 | 162篇 |
1999年 | 156篇 |
1998年 | 102篇 |
1997年 | 90篇 |
1996年 | 85篇 |
1995年 | 74篇 |
1994年 | 78篇 |
1993年 | 72篇 |
1992年 | 107篇 |
1991年 | 90篇 |
1990年 | 94篇 |
1989年 | 75篇 |
1988年 | 99篇 |
1987年 | 93篇 |
1986年 | 72篇 |
1985年 | 80篇 |
1984年 | 73篇 |
1983年 | 75篇 |
1982年 | 46篇 |
1981年 | 43篇 |
1980年 | 36篇 |
1979年 | 42篇 |
1978年 | 48篇 |
1977年 | 35篇 |
1973年 | 38篇 |
1972年 | 34篇 |
1970年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献2.
3.
The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing 总被引:1,自引:0,他引:1
Kevin Conway MRCS ; Patricia Price PhD ; Keith G. Harding FRCS ; Wen G. Jiang MD 《Wound repair and regeneration》2006,14(1):2-10
Wound healing involves a number of cellular and molecular events, many of which are controlled by soluble growth factors. In the process of healing, hepatocyte growth factor, a cytokine known to act as mitogen, motogen, and morphogen, has been postulated to play multiple roles during several stages of this complex biological process. Produced primarily by stromal fibroblasts, hepatocyte growth factor regulates angiogenesis, vascular permeability, cell migration, matrix deposition and degradation, and other biological processes. The current article discusses recent progress in understanding the multiple roles played by this growth factor in tissue repair. 相似文献
4.
Veronique Braud E. Yvonne Jones Andrew McMichael 《European journal of immunology》1997,27(5):1164-1169
Human histocompatibility leukocyte antigen E (HLA-E) and mouse major histocompatibility complex (MHC) class Ib antigen, Qa-1, share the same substitutions at two normally conserved positions 143 and 147, which are likely to affect binding of the C terminus of peptides. Qa-1 is able to bind a peptide derived from the leader sequence of H-2 D and H-2 L molecules. We developed a peptide binding assay in vitro to compare the binding specificity of HLA-E with the mouse MHC class Ib molecule Qa-1. We demonstrate that HLA-E binds, although poorly, the peptide which binds to Qa-1 and that it also binds nonamer signal sequence-derived peptides from human MHC class I molecules. Using alanine and glycine substitutions, we could define primary anchor residues at positions 2 and 9 and secondary anchor residues at position 7 and possibly 3. 相似文献
5.
Leonard A. Jason PhD Steven B. Pokorny PhD Monica Adams MPH Annie Topliff MA Courtney Harris BA Yvonne Hunt PhD 《The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions》2009,18(5):367-374
This study evaluated the effects of tobacco Purchase, Use and Possession (PUP) laws on student perceptions of adolescent tobacco use within towns and schools. Twenty‐four towns were randomly assigned into two conditions, the experimental condition (E PUP) involved efforts to increase both PUP law enforcement and reduce minors' access to commercial sources of tobacco, whereas the control condition (C) focused only on efforts to reduce minors' access to commercial sources of tobacco. A hierarchical linear modeling analytical approach was selected due to the multilevel data and nested design. The present study found that over time, youth in the experimental PUP condition observed less youth tobacco usage at school and in their town, and perceived lower rates of tobacco among their peers at school and among friends than youth in the control condition. The findings suggest that PUP law enforcement might be used to strengthen community norms against youth tobacco use. 相似文献
6.
7.
8.
9.
10.
Uta Syrbe Anja Moebes Jürgen Scholze Alexander Swidsinski Yvonne D?rffel 《Hypertension research》2007,30(6):521-528
Circulating monocytes from hypertensive patients show elevated secretion patterns of pro-inflammatory cytokines, an increased expression of adhesion molecules, and an increased adhesion to vascular endothelial cells. We tested the hypothesis that telmisartan, an angiotensin II type 1 (AT(1)) receptor antagonist, reduces the activation of circulating monocytes from hypertensive patients and diminishes the monocyte-endothelial cell adhesion. Monocytes of 20 hypertensive patients and 20 normotensive controls were isolated by density gradient centrifugation and Dynabeads, and the monocyte adhesion to human aortic endothelial cell monolayers was measured by adhesion assays. To characterize monocyte activation we assessed the expression of activity-related cell surface markers that are also involved in monocyte adhesion to endothelial cells, such as CD11a/b and CD54, as well as the chemokine receptors CCR1, CCR2 and CCR5 before and after telmisartan therapy using flow cytometry. Spontaneous adhesion of monocytes from hypertensive patients and the adhesion after stimulation with angiotensin II were significantly increased compared with those in normotensive controls (p<0.05). Treatment of hypertensive patients with the AT(1) receptor antagonist telmisartan significantly diminished the adhesion of circulating monocytes to human endothelial cells (p=0.02) despite the increase in the expressions of CD11b, CD54 and CCR5 after telmisartan therapy. Reducing monocyte adhesion may be a novel beneficial effect of the AT(1) receptor antagonist telmisartan helping to prevent vascular alterations in hypertension. The mechanism of action remains to be elucidated, since reduction in monocyte adhesion was not attributable to changes in adhesion molecule expression. 相似文献